Author:
Conway Charles R.,Chibnall John T.,Cumming Paul,Mintun Mark A.,Gebara Marie Anne I.,Perantie Dana C.,Price Joseph L.,Cornell Martha E.,McConathy Jonathan E.,Gangwani Sunil,Sheline Yvette I.
Subject
Psychiatry and Mental health,Radiology Nuclear Medicine and imaging,Neuroscience (miscellaneous)
Reference67 articles.
1. The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release;Aihara;Brain Research,2004
2. American Psychiatric Association, 2000. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, American Psychiatric Publishing (Text revision).
3. A rating scale for drug-induced akathisia;Barnes;The Britsh Journal of Psychiatry,1989
4. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants;Berman;CNS Spectrums,2009
5. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study;Berman;Journal of Clinical Psychiatry,2007
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献